Industry payments to hospitalist physicians: a 5-year analysis of the Open Payments programme from 2014 to 2018.
health economics, industry payment, open payment programme, disparities, hospitalist
Health and Medical Administration
We analysed Open Payments programme data (https://openpaymentsdata.cms.gov) on industry-to-physician payments to hospitalists for the years 2014 to 2018. Payments to hospitalists increased by 106.5% from 2014 to 2018 with food and beverage (38.5%) and compensation for services other than consulting (24.3%) being the highest-paid categories. Industry payment to hospitalists was highly skewed with top 10 hospitalists receiving more than 30% of the total payments during the study period. The most common drugs associated with payments were anticoagulant medications (apixaban and rivaroxaban). Industry seems to be spending a significant amount of money to increase awareness of medications among hospitalists. Identification of these trends and potential motives of industry spending is critical to address any potential physician bias.
Publisher or Conference
Internal Medicine Journal
Pakanati KC, Siddamreddy S, Nalleballe K, et al. Industry payments to hospitalist physicians: a 5-year analysis of the Open Payments programme from 2014 to 2018. Intern Med J. 2020;50(12):1547-1550. doi:10.1111/imj.15116